Skip to content

Biportal Endoscopy Spine Surgery (BESS )Versus Unilateral Laminotomy Bilateral Decompression (ULBD ): RCT, Non-inferiority Trial

Outcomes Following Bilateral Decompression Surgery in Lumbar Spinal Stenosis With Biportal Endoscopy Versus Unilateral Laminotomy Technique: A Prospective, Single-blinded, Randomized Controlled Non-inferiority Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03302507
Enrollment
64
Registered
2017-10-05
Start date
2017-11-01
Completion date
2019-10-01
Last updated
2019-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative Lumbar Spinal Stenosis

Brief summary

This study is to compare the clinical outcome between the biportal endoscopic decompression and the unilateral approach bilateral decompression in spinal stenosis

Interventions

PROCEDUREBESS

Biportal endoscopic surgery

PROCEDUREULBD

Unilateral laminotomy bilateral decompression

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
30 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* patients aged between 30 and 80 * patients who has radiating pain (VAS \>=40) on lower extremities with spinal stenosis over Gr B * patients who required one-level decompression between L1 and S1 * those who (only if a signature was obtainable), or whose legal guardian, fully understood the clinical trial details and signed the informed consent form

Exclusion criteria

* Revision surgery * Over spondylolisthesis Gr II * Degenerative lumbar scoliosis (Cobb angle \>20) * herniated disc * patients with a history of other spinal diseases (compression fracture, spondylitis, tumor) * women with positive pregnancy tests before the trial or who planned to become pregnant within the following 3 years * patients with a history of malignant tumor or malignant diseases (but the cases of cured disease with no relapse for the past 5 years were included in the present study) * patients with mental retardation or whose parents or legal guardians were older or had mental disabilities * other patients viewed as inappropriate by the staff

Design outcomes

Primary

MeasureTime frameDescription
Oswestry disability index (ODI)3, 6, and 12, months, and every year, up to 5 year after operationThe ODI is based on a self-administered questionnaire measuring ''back-specific function.'' The questionnaire comprises 10 items, each with 6 levels of response. Each item is scored from 0 to 5, and the total summation is converted to a 0-100 scale. The ODI scores ranges from 0 to 100, with higher scores indicating severe symptoms. This is assessed by ODI survey at 1 year after surgery

Secondary

MeasureTime frameDescription
EQ-5D3, 6, and 12, months, and every year, up to 5 year after operationEQ-5D is a standardized instrument developed by the EuroQol Group as a measure of health-related quality of life that can be used in a wide range of health conditions and treatments. The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. This can be used as a quantitative measure of health outcome that reflects the patient's own judgement. The scores on these five dimensions can be presented as a health profile or can be converted to a single summary index number (utility) reflecting preferability compared to other health profiles.
PainDETECT3, 6, and 12, months, and every year, up to 5 year after operationThe painDETECT Questionnaire (PDQ) is a screening tool designed to detect neuropathic pain in patients with chronic low back pain (LBP) based on self-reported pain characteristics. The degree of the seven types of pain quality, the type of pain pattern, and the presence of radiating pain. From the three components of the PDQ, a total score is calculated; a high score indicates that the pain is likely to have a neuropathic component. Scoring is performed using a scoring manual, and results in a final screening score: a score of 0-12 indicates nociceptive pain, 19-38 indicates neuropathic pain, and 13-18 indicates mixed pain.
Number of participants with treatment-related adverse events as assessed by CTCAE v4.0up to 1 month after operationSurgery related adverse events (incidental durotomy, wound infection, re-operation, re-admission)
Operation durationImmediate after operationIntraoperative time in minutes
Postoperative drainageWithin 3 days after operationTotal drainage after surgery in milli-liter
Amount of transfusionWithin 7 days after operationTotal transfusion during and after surgery in milli-liter
Visual Analog Pain Scale (VAS)4, 8, 12, 24, 48 hours, 2 weeks, 3, 6, and 12, months, and every year, up to 5 year after operationVAS is a measurement score that indicates pain severity status. VAS score comprised a 10-cm line with ''none'' (0) on one end of the scale and ''disabling pain'' (10) on the other.
Creatine phosphokinase level in bloodAt 2 day after surgeryCreatine phosphokinase assessment to measure muscle injury at operation
Postoperative Fentanyl consumptionAt 3 days after operationTotal amount of fentanyl consumption after surgery (PCA dose + rescue dose)
Hospital stayWithin 7 days after operationTotal hospital stay after surgery
Radiographic complicationsevery year, up to 5 year after operation,Disc degeneration, facet degeneration, re-stenosis, back muscle atrophy, kyphotic change, disc rupture
Satisfaction scaleAt 1 year after operationSatisfaction scale is a short self-report questionnaire for evaluating patient satisfaction with the outcome of lumbar decompression surgery. Items are scored on a 7-point Likert scale with response categories consisting from very satisfied (7 points) to very dissatisfied (1 points). Satisfaction after operation at 1 year after surgery
Completeness of decompressionWithin 3 days after operationAfter surgery, degree of decompression was measured using postoperative MRI

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026